glp-1 drug mounjaro Use of the dual GIP/GLP-1 tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with drugs among patients with type 2 diabetes, a large retrospective cohort People take GLP-1 drugs like
Description
Electrolyte supplementation can help manage the transition period
TRIUMPH-4 has already delivered positive topline results
Cardiovascular diabetology
Participants with class III obesity (BMI 40 or higher) were more likely to be late responders, meaning they needed more time to achieve significant weight loss
Evaluating causality of gut microbiota in obesity and diabetes in humans
